Teladoc, Inc. (TDOC) Analysts See $-0.41 EPS

February 22, 2018 - By Henry Gaston

 Teladoc, Inc. (TDOC) Analysts See $ 0.41 EPS

Analysts expect Teladoc, Inc. (NYSE:TDOC) to report $-0.41 EPS on February, 27 after the close.They anticipate $0.10 EPS change or 32.26 % from last quarter’s $-0.31 EPS. After having $-0.55 EPS previously, Teladoc, Inc.’s analysts see -25.45 % EPS growth. The stock increased 2.38% or $0.9 during the last trading session, reaching $38.65. About 1.14M shares traded. Teladoc, Inc. (NYSE:TDOC) has risen 205.04% since February 22, 2017 and is uptrending. It has outperformed by 188.34% the S&P500.

Teladoc, Inc. (NYSE:TDOC) Ratings Coverage

Among 18 analysts covering Teladoc Inc (NYSE:TDOC), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Teladoc Inc had 69 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 3 by Oppenheimer. The stock of Teladoc, Inc. (NYSE:TDOC) has “Buy” rating given on Sunday, December 3 by KeyBanc Capital Markets. The firm earned “Buy” rating on Thursday, March 2 by Chardan Capital Markets. The stock has “Buy” rating by Robert W. Baird on Friday, June 16. The stock of Teladoc, Inc. (NYSE:TDOC) earned “Buy” rating by KeyBanc Capital Markets on Monday, January 8. The company was initiated on Monday, July 27 by JP Morgan. FBR Capital maintained Teladoc, Inc. (NYSE:TDOC) on Tuesday, January 12 with “Outperform” rating. KeyBanc Capital Markets maintained the stock with “Buy” rating in Sunday, September 17 report. The stock of Teladoc, Inc. (NYSE:TDOC) earned “Buy” rating by Canaccord Genuity on Tuesday, January 30. The stock of Teladoc, Inc. (NYSE:TDOC) has “Buy” rating given on Thursday, September 3 by JP Morgan.

Teladoc, Inc. operates a telehealth platform that provides on-demand healthcare services to its members in the United States. The company has market cap of $2.36 billion. The Company’s solution connects clients with its physicians and behavioral health professionals that treat a range of conditions and cases, including acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis; dermatological conditions; anxiety; and smoking cessation. It currently has negative earnings. The firm offers its services through mobile devices, the Internet, video, and phone.

More news for Teladoc, Inc. (NYSE:TDOC) were recently published by: Globenewswire.com, which released: “Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results” on February 13, 2018. Globenewswire.com‘s article titled: “In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System” and published on February 20, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.